戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 with self-expandable nitinol stents for deep venous obstruction.
2 endovenous stent for symptomatic iliofemoral venous obstruction.
3 mplantable electronic device lead-associated venous obstruction.
4 ent in patients with symptomatic iliofemoral venous obstruction.
5 r function, AV valve function, and pulmonary venous obstruction.
6 Central venous catheter thrombosis can cause venous obstruction and pulmonary embolism.
7                              It demonstrated venous obstruction at the level of the subclavian vein a
8                      Symptomatic iliofemoral venous obstruction can be successfully treated with an A
9                               These forms of venous obstruction can result in significant symptoms as
10 deep vein thrombosis and chronic iliofemoral venous obstruction cause substantial patient harm and ar
11                                              Venous obstruction cause was classified as acute deep ve
12        However, prevention of late pulmonary venous obstruction continues to be a cornerstone of succ
13 treatment for central pulmonary arterial and venous obstruction due to mediastinal fibrosis in four p
14 ent to relieve central pulmonary arterial or venous obstruction due to mediastinal fibrosis is an eff
15  revealed two cases of delayed-onset hepatic venous obstruction from anastomotic strictures.
16 ring stent implantation to prevent pulmonary venous obstruction in 4 patients.
17 ep venous thrombosis and chronic iliofemoral venous obstruction in clinical studies and thereby enhan
18                                  Iliofemoral venous obstruction is recognized with increasing frequen
19 ncidence and clinical impact of lead-related venous obstruction (LRVO) among patients with cardiovasc
20                                      Retinal venous obstruction may be the presentation of significan
21 operation (n = 7); 2) those with iliofemoral venous obstruction (n = 6); and 3) those with miscellane
22                                              Venous obstruction of the subclavian, brachiocephalic, o
23 enous stent to treat symptomatic iliofemoral venous obstructions, with reductions in clinical symptom